Cullen/Frost Q3 EPS $2.84, NII Up 5.8%, Q4 Dividend Raised to $1.03
CFR sits 32% above its 52-week low of $119.145.
Summary
Cullen/Frost earned $2.84 per diluted share in Q3 2026 versus $2.67 a year earlier, with net interest income up 5.8% and non-accrual loans nearly halved from mid-year. The board raised the quarterly common dividend to $1.03 and left $125.0M on its buyback authorization.
Key Events · Earnings and Guidance · CFR
-
Q3 EPS $2.84, Net Income $178.5M
Net income available to common shareholders rose to $178.5M from $172.7M a year earlier; diluted EPS $2.84 versus $2.67. Nine-month EPS was $8.19, up 11.3%.
-
Net Interest Income Up 5.8%
Taxable-equivalent net interest income was $490.8M versus $463.7M, with the margin at 3.78% against 3.69% a year ago and 3.75% in Q2 2026.
-
Loan and Deposit Growth Accelerates
Average loans rose 9.0% to $23.4B and average deposits 3.6% to $43.6B year over year; loans were up 3.3% and deposits 2.3% from Q2 2026.
-
Credit Improves, Non-Accruals Halve
Non-accrual loans fell to $63.7M from $112.7M at June 30, 2026, while credit loss expense rose to $12.1M from $9.8M in Q2 and net charge-offs were $8.4M.
Analysis · CFR · Finance
Cullen/Frost delivered a clean quarter: EPS of $2.84 versus $2.67 a year ago, net interest income up 5.8% to $490.8M and margin widening to 3.78% from 3.69%. Loan growth of 9.0% and deposit growth of 3.6% show the Texas expansion is still adding volume, and credit looks better, not worse — non-accrual loans dropped to $63.7M from $112.7M at mid-year even as credit loss expense ticked up to $12.1M. The board lifted the quarterly common dividend to $1.03 from $1.00 and still has $125.0M left on its buyback authorization through January 2027. The one soft spot is expense growth of 7.0%, faster than revenue, driven by hiring and $6.4M more advertising spend.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CFR was trading at $157.58 on NYSE in the Finance sector, with a market capitalization of approximately $9.8B. The 52-week trading range was $119.15 to $170.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.